BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10538230)

  • 1. Matters of the heart. Life-saving drugs for cardiac disease are still underused.
    Paul KJ
    Contemp Longterm Care; 1999 Jun; 22(6):53. PubMed ID: 10538230
    [No Abstract]   [Full Text] [Related]  

  • 2. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the EuroHeart Failure Survey.
    Hülsmann M; Berger R; Mörtl D; Pacher R
    Eur J Heart Fail; 2005 Jun; 7(4):657-61. PubMed ID: 15921808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R
    Vasc Health Risk Manag; 2005; 1(3):171-2. PubMed ID: 17319102
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
    Sabatini T; Rozzini R; Trabucchi M
    Circulation; 2005 May; 111(17):e276-7; author reply e276-7. PubMed ID: 15867189
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart failure management: caregiver versus care plan.
    Kim DH; Hunt SA
    Circulation; 2003 Jul; 108(2):129-31. PubMed ID: 12860891
    [No Abstract]   [Full Text] [Related]  

  • 8. [ACE inhibitor and beta blocker are indispensible in heart failure. With adverse effects consider concomitant medication first].
    Neumaier J
    MMW Fortschr Med; 2004 Mar; 146(12):14. PubMed ID: 15357498
    [No Abstract]   [Full Text] [Related]  

  • 9. Getting ACE inhibitors into the right hands.
    Bilodeau A
    Manag Care; 1997 Jan; 6(1):31-2. PubMed ID: 10164530
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment gaps in the pharmacologic management of heart failure.
    Gheorghiade M; Gattis WA; O'Connor CM
    Rev Cardiovasc Med; 2002; 3 Suppl 3():S11-9. PubMed ID: 12447157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the quality of care for patients with coronary heart disease: the design and baseline results of the hastening the effective application of research through technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Parker DG; Cohen SJ
    Am J Manag Care; 2002 Dec; 8(12):1069-78. PubMed ID: 12500883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
    Houpe D; Peltier M; Cohen-Solal A; Béguin M; Lévy F; Slama M; Chapelain K; Tribouilloy C
    Int J Cardiol; 2005 Sep; 103(3):286-92. PubMed ID: 16098391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in heart failure medications in patients hospitalised and discharged.
    Scherer M; Sobek C; Wetzel D; Koschack J; Kochen MM
    BMC Fam Pract; 2006 Nov; 7():69. PubMed ID: 17123439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observations on the management of cardiac failure in ambulatory patients. Results of a survey of cardiologists].
    Komajda M; Bouhour JB; Amouyel P; Delahaye F; Vicaut E; Croce I; Rougemond E; Vuittenez F; Leutenegger E
    Arch Mal Coeur Vaiss; 2001 Apr; 94(4):257-61. PubMed ID: 11387930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of evidence-based therapies for heart failure in the institutionalized elderly.
    Shibata MC; Soneff CM; Tsuyuki RT
    Eur J Heart Fail; 2005 Dec; 7(7):1122-5. PubMed ID: 16043409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta blockers in systolic heart failure.
    Jackowski L; Azam R
    Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure--and an interaction with beta blockade.
    Coats AJ
    Int J Cardiol; 2001 Jan; 77(1):1-4. PubMed ID: 11150619
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence-based use of medications in patients with coronary artery disease in a rural Australian community.
    Granmyr J; Ball P; Curran S; Wang L
    Aust J Rural Health; 2007 Aug; 15(4):241-6. PubMed ID: 17617087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should beta-blockers form the cornerstone for the treatment of congestive heart failure?
    Tabrizchi R
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):157-60. PubMed ID: 15030275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.